Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 59

Results For "capital"

708 News Found

Vantage Specialty Chemicals acquires JEEN
News | March 08, 2022

Vantage Specialty Chemicals acquires JEEN

JEEN’s portfolio includes a diverse range of specialized active ingredients, botanical extracts, and complexes serving functional applications for skin and hair care


Evonik invests in US-based 3D screen printing technology firm Laxxon Medical
News | March 07, 2022

Evonik invests in US-based 3D screen printing technology firm Laxxon Medical

Laxxon Medical has developed a 3D screen printing technology for the manufacture of structured tablets that enables the controlled release of active pharmaceutical ingredients over time


Limited impact of short-term disruptions, growth momentum to continue in FY 23
News | March 03, 2022

Limited impact of short-term disruptions, growth momentum to continue in FY 23

Large players are adequately capitalised to make bigger investments to adjust for the ongoing fundamental shift in market opportunities


Merck KGaA reports higher profits on strong volumes across its businesses
News | March 03, 2022

Merck KGaA reports higher profits on strong volumes across its businesses

Company expects strong organic growth in sales, EBITDA in 2022


Industry seeks favourable policy for India to move up the pharma value chain globally
Policy | February 27, 2022

Industry seeks favourable policy for India to move up the pharma value chain globally

N Yuvraj, Joint Secretary, Dept of Pharmaceuticals, Satish Reddy, Chairman, Dr Reddy’s Laboratories; Kiran Mazumdar Shaw, Executive Chairperson, Biocon Group; Sanjiv Navangul, MD & CEO, Bharat Serums and Vaccines and Shravil Patel, MD, Zydus Lifesciences discuss the way forward for the India pharma industry


Elanco announces appointment of Rajeev (Bobby), Modi as Executive VP, U.S. Pet Health
People | February 24, 2022

Elanco announces appointment of Rajeev (Bobby), Modi as Executive VP, U.S. Pet Health

Modi holds a bachelor's degree in Chemical Engineering from University of Cincinnati and a master’s degree in Marketing, Management Strategy and Finance from Northwestern’s Kellogg School of Management


Ruby Chandy elected to the board of Thermo Fisher Scientific
People | February 24, 2022

Ruby Chandy elected to the board of Thermo Fisher Scientific

Chandy was the president of the Industrial Division of Pall Corporation, a leading supplier of filtration, separation, and purification technologies. Previously, she was chief marketing officer at the Dow Chemical Company and Rohm and Haas Corporation


GSK introduces Haleon to the world
News | February 23, 2022

GSK introduces Haleon to the world

Haleon will have a portfolio of category-leading brands including Sensodyne, Voltaren, Panadol and Centrum


ACUITE upgrades ratings of Bal Pharma
News | February 23, 2022

ACUITE upgrades ratings of Bal Pharma

The group had witnessed healthy revenue growth as revenue stood at Rs 251.14 crore in FY21.


Complement Therapeutics raises €5 million seed financing
News | February 23, 2022

Complement Therapeutics raises €5 million seed financing

Appoints Dr Rafiq Hasan as CEO